Skip to content

In vivo sentinel node procedure in patients with resectable colon cancer, a pilot study.

In vivo sentinel node procedure in patients with resectable colon cancer, a pilot study. - VISCO study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33423
Enrollment
30
Registered
2009-11-27
Start date
2009-11-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer large bowel cancer

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Resectabel colon cancer treated with segmental colectomy, in an elective setting, open or minimal invasive. >18 years ASA I-III no known allergy for patent blue

Exclusion criteria

Exclusion criteria: rectal cancer earlier colonic surgery pregnancy age

Design outcomes

Primary

MeasureTime frame
Number of successful SN-procedures.

Secondary

MeasureTime frame
Number of problems encountered during the SN-procedure. Number of resected and examined lymph nodes in the SN-group and the standard group. Number of examined lymph nodes when the pathologist is handed a X-ray of the specimen.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)